These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12761502)

  • 1. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
    Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
    Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new member of the ETS family fused to EWS in Ewing tumors.
    Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
    Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression by the proto-oncogene BCL-6.
    Seyfert VL; Allman D; He Y; Staudt LM
    Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family.
    Schneikert J; Lutz Y; Wasylyk B
    Oncogene; 1992 Feb; 7(2):249-56. PubMed ID: 1549346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Ets function by protein - protein interactions.
    Li R; Pei H; Watson DK
    Oncogene; 2000 Dec; 19(55):6514-23. PubMed ID: 11175367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of mammalian transcriptional repressors.
    Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
    Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
    Wang L; Hiebert SW
    Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1.
    Wang Y; Li Y; Qi X; Yuan W; Ai J; Zhu C; Cao L; Yang H; Liu F; Wu X; Liu M
    Biochem Biophys Res Commun; 2004 Oct; 323(1):9-16. PubMed ID: 15351693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets-2 interacts with co-repressor BS69 to repress target gene expression.
    Wei G; Schaffner AE; Baker KM; Mansky KC; Ostrowski MC
    Anticancer Res; 2003; 23(3A):2173-8. PubMed ID: 12894593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
    Li R; Pei H; Watson DK; Papas TS
    Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the ets-related human transcription factor ER81.
    Monté D; Coutte L; Baert JL; Angeli I; Stéhelin D; de Launoit Y
    Oncogene; 1995 Aug; 11(4):771-9. PubMed ID: 7651741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression.
    Heinzel T; Lavinsky RM; Mullen TM; Söderstrom M; Laherty CD; Torchia J; Yang WM; Brard G; Ngo SD; Davie JR; Seto E; Eisenman RN; Rose DW; Glass CK; Rosenfeld MG
    Nature; 1997 May; 387(6628):43-8. PubMed ID: 9139820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
    Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
    Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the transcriptional repression domain of nuclear factor 1-A.
    Osada S; Ikeda T; Xu M; Nishihara T; Imagawa M
    Biochem Biophys Res Commun; 1997 Sep; 238(3):744-7. PubMed ID: 9325160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation.
    Criqui-Filipe P; Ducret C; Maira SM; Wasylyk B
    EMBO J; 1999 Jun; 18(12):3392-403. PubMed ID: 10369679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110.
    Cohen SB; Nicol R; Stavnezer E
    Oncogene; 1998 Nov; 17(19):2505-13. PubMed ID: 9824161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression.
    Wang Z; Wang DZ; Hockemeyer D; McAnally J; Nordheim A; Olson EN
    Nature; 2004 Mar; 428(6979):185-9. PubMed ID: 15014501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.